Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer’s Disease
出版年份 2021 全文链接
标题
Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer’s Disease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 20, Pages 10903
出版商
MDPI AG
发表日期
2021-10-11
DOI
10.3390/ijms222010903
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cardiolipin, Mitochondria, and Neurological Disease
- (2021) Micol Falabella et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features
- (2020) Alfonso Di Costanzo et al. Scientific Reports
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics
- (2019) Yogatheesan Varatharajah et al. Scientific Reports
- Metabolomics in the Development and Progression of Dementia: A Systematic Review
- (2019) Yanfeng Jiang et al. Frontiers in Neuroscience
- Multi-Omic Analysis of the Microbiome and Metabolome in Healthy Subjects Reveals Microbiome-Dependent Relationships Between Diet and Metabolites
- (2019) Zheng-Zheng Tang et al. Frontiers in Genetics
- Computational Methods for the Discovery of Metabolic Markers of Complex Traits
- (2019) Michael Lee et al. Metabolites
- Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota
- (2019) Binyin Li et al. Alzheimers & Dementia
- Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
- (2018) Vijay R. Varma et al. PLOS MEDICINE
- Cardiolipin Profile Changes are Associated to the Early Synaptic Mitochondrial Dysfunction in Alzheimer's Disease
- (2018) Vera F. Monteiro-Cardoso et al. JOURNAL OF ALZHEIMERS DISEASE
- Microbial tryptophan catabolites in health and disease
- (2018) Henrik M. Roager et al. Nature Communications
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer's disease mouse model
- (2018) Sujyoti Chandra et al. NEUROBIOLOGY OF DISEASE
- Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015
- (2017) Dev Mehta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Polyphenols journey through blood-brain barrier towards neuronal protection
- (2017) I. Figueira et al. Scientific Reports
- Gut microbiome alterations in Alzheimer’s disease
- (2017) Nicholas M. Vogt et al. Scientific Reports
- Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals
- (2016) Ramon Casanova et al. Alzheimers & Dementia
- Does mild cognitive impairment always lead to dementia? A review
- (2016) Seema Y. Pandya et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
- (2015) Massimo S. Fiandaca et al. Frontiers in Neurology
- The critical need for defining preclinical biomarkers in Alzheimer's disease
- (2014) Massimo S. Fiandaca et al. Alzheimers & Dementia
- Biomarkers in dementia: clinical utility and new directions
- (2014) R M Ahmed et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma Metabolite Profiles of Alzheimer’s Disease and Mild Cognitive Impairment
- (2014) Gang Wang et al. JOURNAL OF PROTEOME RESEARCH
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Random Forest in Clinical Metabolomics for Phenotypic Discrimination and Biomarker Selection
- (2013) Tianlu Chen et al. Evidence-based Complementary and Alternative Medicine
- A new metabolomic workflow for early detection of Alzheimer's disease
- (2013) Clara Ibáñez et al. JOURNAL OF CHROMATOGRAPHY A
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
- (2013) Eugenia Trushina et al. PLoS One
- Reversion from mild cognitive impairment to normal or near-normal cognition: Risk factors and prognosis
- (2012) T. D. Koepsell et al. NEUROLOGY
- Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers
- (2012) Daoqiang Zhang et al. PLoS One
- Les nouvelles recommandations 2011 du National Institute on Aging et de l’Alzheimer's Association sur le diagnostic de la maladie d’Alzheimer : stades précliniques, mild cognitive impairment et démence
- (2012) B. Croisile et al. REVUE NEUROLOGIQUE
- Metabolome in progression to Alzheimer's disease
- (2011) M Orešič et al. Translational Psychiatry
- Blood-based biomarkers of Alzheimer’s disease: challenging but feasible
- (2010) Madhav Thambisetty et al. Biomarkers in Medicine
- In silico fragmentation for computer assisted identification of metabolite mass spectra
- (2010) Sebastian Wolf et al. BMC BIOINFORMATICS
- Analytical Error Reduction Using Single Point Calibration for Accurate and Precise Metabolomic Phenotyping
- (2009) Frans M. van der Kloet et al. JOURNAL OF PROTEOME RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started